These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6269241

  • 1. Biochemical subgrouping of benign breast disease to define premalignant potential.
    Minton JP, Abou-Issa H, Elliot JB, Foecking MK, Roseman JM, Matthews RH.
    Surgery; 1981 Oct; 90(4):652-6. PubMed ID: 6269241
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of cellular DNA in the study of the relations between fibrocystic disease of the breast and breast cancer].
    Lazzari G, Lamarca S.
    Arch Sci Med (Torino); 1977 Oct; 134(2):137-44. PubMed ID: 869700
    [Abstract] [Full Text] [Related]

  • 3. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S.
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [Abstract] [Full Text] [Related]

  • 4. Cyclic adenosine 3':5'-monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptors.
    Handschin JC, Handloser K, Takahashi A, Eppenberger U.
    Cancer Res; 1983 Jun; 43(6):2947-54. PubMed ID: 6303571
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 and cyclic AMP levels in human breast tumors.
    Feller N, Malachi T, Halbrecht I.
    J Cancer Res Clin Oncol; 1979 Apr 12; 93(3):275-80. PubMed ID: 224064
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
    Manfrin E, Mariotto R, Remo A, Reghellin D, Falsirollo F, Dalfior D, Bricolo P, Piazzola E, Bonetti F.
    Cancer; 2009 Feb 01; 115(3):499-507. PubMed ID: 19117040
    [Abstract] [Full Text] [Related]

  • 14. Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation.
    Iglesias A, Arias M, Santiago P, Rodríguez M, Mañas J, Saborido C.
    Curr Probl Diagn Radiol; 2007 Feb 01; 36(2):66-82. PubMed ID: 17331838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preneoplasia of the breast.
    Böcker W.
    Verh Dtsch Ges Pathol; 1997 Feb 01; 81():502-13. PubMed ID: 9474891
    [Abstract] [Full Text] [Related]

  • 19. [Cyclic adenosine monophosphate in the fatty tissue of breast and lung cancer patients].
    Bershteĭn LM, Seleznev IK, Lemekhov VG.
    Vopr Med Khim; 1981 Feb 01; 27(5):607-11. PubMed ID: 6274096
    [Abstract] [Full Text] [Related]

  • 20. [Hormone receptors and precancerous lesions of the breast].
    Mignot L, Espie M, de Roquancourt A, Gorins A.
    Pathol Biol (Paris); 1983 Nov 01; 31(9):761-4. PubMed ID: 6318180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.